Anthropic opens Bay Area biology lab to accelerate AI drug research

Anthropic has quietly established a physical biology laboratory in the San Francisco Bay Area, marking its expansion into drug science as it develops AI for life sciences applications. The startup confirmed it is conducting real-world lab work alongside computer-based evaluations. The company's head of life sciences, Eric Kauderer-Abrams, said the wet lab is essential because final biological testing requires physical experiments, with work split between in-house facilities and external partners. Anthropic aims to accelerate treatments for rare diseases, though a spokesperson clarified the lab is not specifically for drug discovery. Anthropic's broader ambition includes tackling neglected diseases, but most drug candidates fail clinical trials. The company has acquired startup Coefficient Bio, added a Novartis executive to its board, and is hiring for lab operations roles, while navigating public concerns about AI risks and preparing for a potential IPO.